Michael J. Grayling

1.4k total citations · 1 hit paper
58 papers, 738 citations indexed

About

Michael J. Grayling is a scholar working on Statistics and Probability, Economics and Econometrics and Management Science and Operations Research. According to data from OpenAlex, Michael J. Grayling has authored 58 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Statistics and Probability, 18 papers in Economics and Econometrics and 15 papers in Management Science and Operations Research. Recurrent topics in Michael J. Grayling's work include Statistical Methods in Clinical Trials (38 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Optimal Experimental Design Methods (14 papers). Michael J. Grayling is often cited by papers focused on Statistical Methods in Clinical Trials (38 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Optimal Experimental Design Methods (14 papers). Michael J. Grayling collaborates with scholars based in United Kingdom, New Zealand and Switzerland. Michael J. Grayling's co-authors include Adrian Mander, B. P. Sweeney, James Wason, Charles D. Deakin, Karla Hemming, Caroline Kristunas, Mary Dixon‐Woods, A. Doussau, Andrew Copas and Joanne E. McKenzie and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, BMJ and Journal of Clinical Epidemiology.

In The Last Decade

Michael J. Grayling

51 papers receiving 718 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration

2018 247 citations Karla Hemming, Monica Taljaard et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. Grayling United Kingdom	11	217	132	132	117	86	58	738
D. G. Altman United Kingdom	5	143 0.7×	103 0.8×	174 1.3×	11 0.1×	69 0.8×	6	743
Harriet F. Peterson United States	17	114 0.5×	116 0.9×	223 1.7×	14 0.1×	146 1.7×	23	1.3k
Iván Díaz United States	22	353 1.6×	52 0.4×	153 1.2×	9 0.1×	58 0.7×	97	1.3k
Thomas A. Murray United States	14	169 0.8×	435 3.3×	73 0.6×	12 0.1×	15 0.2×	48	1.4k
Ulka B. Campbell United States	17	129 0.6×	105 0.8×	152 1.2×	5 0.0×	89 1.0×	31	1.0k
Robert LoCasale United States	14	85 0.4×	200 1.5×	74 0.6×	75 0.6×	21 0.2×	23	602
SJ Pocock United Kingdom	11	199 0.9×	138 1.0×	134 1.0×	6 0.1×	19 0.2×	16	1.0k
A. Doussau France	6	45 0.2×	217 1.6×	66 0.5×	7 0.1×	74 0.9×	12	609
Bray Patrick‐Lake United States	14	134 0.6×	52 0.4×	323 2.4×	5 0.0×	248 2.9×	18	916
Valeria Pacheco‐Huergo Spain	10	173 0.8×	110 0.8×	260 2.0×	3 0.0×	140 1.6×	14	768

Countries citing papers authored by Michael J. Grayling

Since Specialization

Citations

This map shows the geographic impact of Michael J. Grayling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Grayling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Grayling more than expected).

Fields of papers citing papers by Michael J. Grayling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Grayling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Grayling. The network helps show where Michael J. Grayling may publish in the future.

Co-authorship network of co-authors of Michael J. Grayling

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Grayling. A scholar is included among the top collaborators of Michael J. Grayling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Grayling. Michael J. Grayling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wason, James, et al.. (2024). A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes. Statistics in Medicine. 43(24). 4736–4751.

Robertson, David S., Thomas J Burnett, Babak Choodari‐Oskooei, et al.. (2024). Confidence intervals for adaptive trial designs I: A methodological review. arXiv (Cornell University).

Wason, James, et al.. (2023). A Comparison of Randomization Methods for Multi-Arm Clinical Trials. Statistics in Biopharmaceutical Research. 16(2). 205–217. 1 indexed citations

Grayling, Michael J., James Wason, & Sofía S. Villar. (2022). Response adaptive intervention allocation in stepped‐wedge cluster randomized trials. Statistics in Medicine. 41(6). 1081–1099. 2 indexed citations

Kunzmann, Kevin, et al.. (2022). Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials. Statistics in Medicine. 41(5). 877–890. 8 indexed citations

Wason, James, et al.. (2022). A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation. Clinical Trials. 20(1). 59–70. 4 indexed citations

Grayling, Michael J., Adrian Mander, Nurulamin M Noor, et al.. (2022). Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information. Journal of Clinical Epidemiology. 150. 72–79. 8 indexed citations

Grayling, Michael J. & James Wason. (2022). Point estimation following a two-stage group sequential trial. Statistical Methods in Medical Research. 32(2). 287–304. 3 indexed citations

Grayling, Michael J., et al.. (2021). Characterising the allergic profile of children with cystic fibrosis. Immunity Inflammation and Disease. 10(1). 60–69. 3 indexed citations

10.

Grayling, Michael J., et al.. (2021). Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methods. Pharmaceutical Statistics. 20(6). 990–1001. 2 indexed citations

11.

Mossop, Helen, Michael J. Grayling, Ferdia A. Gallagher, et al.. (2021). Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials. British Journal of Cancer. 126(2). 204–210. 1 indexed citations

12.

Grayling, Michael J., et al.. (2021). Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential. BMC Rheumatology. 5(1). 21–21. 13 indexed citations

13.

Kunzmann, Kevin, et al.. (2021). A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials. The American Statistician. 75(4). 424–432. 9 indexed citations

14.

Grayling, Michael J. & Graham Wheeler. (2020). A review of available software for adaptive clinical trial\ndesign. Europe PMC (PubMed Central). 18 indexed citations

15.

Law, Martin, Michael J. Grayling, & Adrian Mander. (2020). A stochastically curtailed two‐arm randomised phaseIItrial design for binary outcomes. Pharmaceutical Statistics. 20(2). 212–228. 4 indexed citations

16.

Grayling, Michael J., et al.. (2019). Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study. Trials. 20(1). 665–665. 3 indexed citations

17.

Grayling, Michael J., Adrian Mander, & James Wason. (2019). Two-Stage Adaptive Designs for Three-Treatment Bioequivalence Studies. Statistics in Biopharmaceutical Research. 11(4). 360–374. 2 indexed citations

18.

Grayling, Michael J., James Wason, & Adrian Mander. (2018). . Newcastle University ePrints (Newcastle Univesity). 2 indexed citations

19.

Hemming, Karla, Monica Taljaard, Joanne E. McKenzie, et al.. (2018). Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ. 363. k1614–k1614. 247 indexed citations breakdown →

20.

Grayling, Michael J., Iain H. Wilson, & B M Thomas. (2002). The use of the laryngeal mask airway and Combitube® in cardiopulmonary resuscitation; a national survey. Resuscitation. 52(2). 183–186. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact